Literature DB >> 6690359

Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux.

B B Dahms, F C Rothstein.   

Abstract

It is widely acknowledged that Barrett's esophagus in adults is an acquired condition resulting from prolonged gastroesophageal reflux. Barrett's esophagus is rare in childhood, even though gastroesophageal reflux occurs commonly in the pediatric age group. When a columnar-lined esophagus is present in children, it is often regarded as a congenital anomaly rather than as a consequence of chronic gastroesophageal reflux. Over a 5-yr period (1978-1982), we retrospectively studied Barrett's esophagus in children 19 yr of age or younger who were evaluated for gastroesophageal reflux and whose symptoms warranted esophagoscopy and esophageal biopsy. Esophageal biopsies were performed on 103 patients with gastroesophageal reflux. Thirteen children (age range, 8 mo-19 yr) had Barrett's esophagus, for a prevalence of 13%. Gastroesophageal reflux was documented in these children by upper gastrointestinal radiographs or pH monitoring. Radiographs demonstrated esophageal stricture in 5 of the 13 children; none had hiatal hernia. Children presented with symptoms suggestive of gastroesophageal reflux and esophagitis: vomiting, abdominal pain, odynophagia, dysphagia, and heartburn. All children had a past history of excessive regurgitation during infancy. Histologically, three types of columnar epithelium were present: gastric fundic type (11 patients), junctional-type columnar epithelium reminiscent of gastric cardia (7 patients), and specialized columnar (metaplastic intestinal) type (2 patients). We believe that Barrett's esophagus is more common in children than had previously been appreciated. In these children, we suggest that the distal columnar-lined esophagus resulted from chronic gastroesophageal reflux and is not a congenital anomaly.

Entities:  

Mesh:

Year:  1984        PMID: 6690359

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Barrett's esophagus in children and young adults. Frequent association with mental retardation.

Authors:  J D Snyder; H Goldman
Journal:  Dig Dis Sci       Date:  1990-10       Impact factor: 3.199

Review 2.  Pathogenesis of columnar-lined esophagus.

Authors:  Kamal E Bani-Hani; Bayan K Bani-Hani
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 3.  Barrett esophagus: histology and pathology for the clinician.

Authors:  Robert D Odze
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

4.  Progression of Barrett's mucosa to adenocarcinoma after antireflux surgery: radiologic-pathologic correlation.

Authors:  F P Agha
Journal:  Dysphagia       Date:  1987       Impact factor: 3.438

5.  Benign oesophageal stricture in Barrett's columnar epithelialised oesophagus and its responsiveness to conservative management.

Authors:  M Atkinson; C S Robertson
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

Review 6.  Epidemiology of gastro-esophageal reflux disease.

Authors:  P J Howard; R C Heading
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

7.  Ornithine decarboxylase (ODC) levels in children with reflux esophagitis.

Authors:  Y Elitsur; W E Triest; C H Lin
Journal:  Dig Dis Sci       Date:  1994-04       Impact factor: 3.199

8.  Upper oesophageal gastric heterotopia: a prospective necropsy study in children.

Authors:  S Variend; A J Howat
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

9.  Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

10.  Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus.

Authors:  Hejin P Hahn; Patricia L Blount; Kamrun Ayub; Kiron M Das; Rhonda Souza; Stuart Spechler; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2009-07       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.